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ABSTRACT 15 
Although several sleep-regulating neurons have been identified, little is known about how they 16 
interact with each other for sleep/wake control. We previously identified neuropeptide VF (NPVF) 17 
and the hypothalamic neurons that produce it as a sleep-promoting system (Lee et al., 2017). 18 
Here we use zebrafish to describe a neural circuit in which neuropeptide VF (npvf)-expressing 19 
neurons control sleep via the serotonergic raphe nuclei (RN), a hindbrain structure that promotes 20 
sleep in both diurnal zebrafish and nocturnal mice. Using genetic labeling and calcium imaging, 21 
we show that npvf-expressing neurons innervate and activate serotonergic RN neurons. We 22 
additionally demonstrate that optogenetic stimulation of npvf-expressing neurons induces sleep 23 
in a manner that requires NPVF and is abolished when the RN are ablated or lack serotonin. 24 
Finally, genetic epistasis demonstrates that NPVF acts upstream of serotonin in the RN to 25 
maintain normal sleep levels. These findings reveal a novel hypothalamic-hindbrain circuit for 26 
sleep/wake control. 27 
  28 
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INTRODUCTION 29 
While several sleep- and wake-promoting neuronal populations have been identified (reviewed in 30 
(Bringmann, 2018; Liu and Dan, 2019; Saper and Fuller, 2017; Scammell et al., 2017)), 31 
characterizing and understanding the functional and hierarchical relationships between these 32 
populations is essential for understanding how the brain regulates sleep and wake states 33 
(Oikonomou and Prober, 2017). Recent evidence from zebrafish and mice demonstrate that the 34 
serotonergic raphe nuclei (RN) are critical for the initiation and maintenance of sleep (Oikonomou 35 
et al., 2019), in contrast with previous models suggesting a wake-promoting role for the RN that 36 
were largely based on their wake-active nature (Saper and Fuller, 2017; Scammell et al., 2017; 37 
Weber and Dan, 2016). In zebrafish, mutation of tryptophan hydroxylase 2 (tph2), which is 38 
required for serotonin (5-HT) synthesis in the RN, results in reduced sleep, sleep depth, and 39 
homeostatic response to sleep deprivation (Oikonomou et al., 2019). Pharmacological inhibition 40 
of 5-HT synthesis or ablation of the RN also results in reduced sleep. Consistent with a sleep-41 
promoting role for the raphe, optogenetic stimulation of raphe neurons results in increased sleep. 42 
Similarly, in mice, ablation of the RN results in increased wakefulness and an impaired 43 
homeostatic response to sleep deprivation, whereas tonic optogenetic stimulation of the RN at a 44 
rate similar to their baseline pattern of activity induces NREM sleep. These complementary results 45 
in zebrafish and mice (Oikonomou et al., 2019), along with classical ablation and pharmacological 46 
studies (Ursin, 2008), indicate an evolutionarily conserved role for the serotonergic system in 47 
promoting vertebrate sleep. However, it is unclear how the RN are themselves regulated to 48 
promote sleep. 49 
 50 
Trans-synaptic retrograde viral tracing studies have identified substantial inputs to the RN from 51 
hypothalamic neurons in the lateral hypothalamic area, tuberomammillary nucleus, and 52 
dorsomedial nucleus, regions implicated in sleep-wake regulation (Pollak Dorocic et al., 2014; 53 
Ren et al., 2018; Weissbourd et al., 2014). However, it is unknown whether any of these or other 54 
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populations act upon the RN to promote sleep. One candidate neuronal population expresses the 55 
sleep-promoting neuropeptide VF (NPVF) in ~25 neurons in the larval zebrafish hypothalamus 56 
(Lee et al., 2017). Overexpression of npvf or stimulation of npvf-expressing neurons results in 57 
increased sleep, whereas pharmacological inhibition of NPVF signaling or ablation of npvf-58 
expressing neurons results in reduced sleep (Lee et al., 2017). While it is unknown how the NPVF 59 
system promotes sleep, these neurons densely innervate a region of the hindbrain that is 60 
consistent with the location of the RN (Lee et al., 2017; Madelaine et al., 2017). Because 61 
perturbations of the NPVF system and RN have similar effects on sleep, and processes of npvf-62 
expressing neurons are found near the RN, we hypothesized that the NPVF system promotes 63 
sleep via the RN. To test this hypothesis, we used genetics, optogenetics, and chemogenetics to 64 
dissect the functional relationship between these two neuronal populations. Our results support 65 
the hypothesis that the NPVF system promotes sleep via the RN, thus revealing a novel 66 
hypothalamus-hindbrain neural circuit for sleep-wake control. 67 
 68 
RESULTS 69 
NPVF neurons densely innervate the serotonergic inferior raphe nuclei 70 
In most vertebrates, the RN are the main source of serotonergic innervation in the brain. In 71 
mammals, the RN are divided into a rostral or superior group that lies on the midbrain/pons 72 
boundary (groups B5–B9) (Dahlstroem and Fuxe, 1964), and a caudal or inferior group in the 73 
medulla (groups B1–B3). Similarly, in zebrafish larvae, the RN are divided into the superior raphe 74 
(SRa) and inferior raphe (IRa) (Lillesaar et al., 2009). 75 
 76 
To explore whether the NPVF system may promote sleep via the RN, we first performed a detailed 77 
histological analysis of these populations using Tg(npvf:eGFP) (Lee et al., 2017) and 78 
Tg(npvf:KalTA4); Tg(UAS:nfsb-mCherry) (Agetsuma et al., 2010; Lee et al., 2017) animals, which 79 
specifically label npvf-expressing neurons. As previously described (Lee et al., 2017), the soma 80 
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of npvf-expressing neurons are present exclusively in the dorsomedial hypothalamus at 6 days 81 
post-fertilization (dpf) (Figure 1A,B,D). These neurons send dense and local ramifying projections 82 
into the hypothalamus (Figure 1B,D), as well as longer-range projections into the telencephalon 83 
and hindbrain, with a prominent convergence of these projections at the rostral IRa, as confirmed 84 
using 5-HT immunohistochemistry (IHC) (Figure 1B-1K, Figure 1 - figure supplement 1A-B). 85 
These projections form a dense bundle just ventral to the soma of the IRa and also extend dorsally 86 
where they appear to make multiple contacts with IRa somas. As additional confirmation of this 87 
interaction, we mated Tg(npvf:KalTA4); Tg(UAS:nfsb-mCherry) (Agetsuma et al., 2010; Lee et 88 
al., 2017) animals, in which NPVF neurons and their processes are labeled with mCherry, to 89 
Tg(tph2:eNTR-mYFP) animals, in which the SRa and IRa are labeled with membrane-targeted 90 
YFP (Oikonomou et al., 2019). We observed apparent direct contacts of NPVF neuron fibers with 91 
mYFP-labeled IRa soma and fibers (Figure 1 - figure supplement 1C-E), consistent with a direct 92 
interaction between NPVF and IRa neurons. 93 
 94 
Optogenetic stimulation of NPVF neurons results in activation of serotonergic IRa neurons  95 
Based on our histological observations, we hypothesized that NPVF neurons are functionally 96 
connected to serotonergic IRa neurons, and that stimulation of NPVF neurons should thus 97 
activate IRa neurons. To test this hypothesis, we used Tg(npvf:ReaChR-98 
mCitrine);Tg(tph2:GCaMP6s-tdTomato) animals (Lee et al., 2017; Oikonomou et al., 2019) to 99 
optogenetically stimulate NPVF neurons while monitoring the activity of IRa neurons. Because 100 
neurons in the RN are responsive to visible light (Cheng et al., 2016), we used invisible 920 nm 101 
two-photon light at low laser power to excite GCaMP6s fluorescence. We also used 920 nm two-102 
photon light, applied at higher power, to stimulate ReaChR in NPVF neurons. 103 
 104 
To verify that this stimulation paradigm indeed results in stimulation of NPVF neurons, we first 105 
tested Tg(npvf:ReaChR-mCitrine); Tg(npvf:GCaMP6s-tdTomato) animals (Lee et al., 2017; Lee 106 
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et al., 2019). We first recorded baseline GCaMP6s fluorescence in npvf-expressing neurons, then 107 
optogenetically stimulated these neurons, and then recorded post-stimulation GCaMP6s 108 
fluorescence in these neurons (Figure 2 - figure supplement 1). In the frame after compared to 109 
the frame before optogenetic stimulation, we observed a 165% increase in GCaMP6s 110 
fluorescence in NPVF neurons in Tg(npvf:ReaChR-mCitrine) animals (p<0.0005, Mann-Whitney 111 
test, 5 animals, 86 neurons) (Figure 2 - figure supplement 1H,I). In contrast, there was a 3% 112 
decrease in GCaMP6s fluorescence in the first frame after compared to the frame before 113 
optogenetic stimulation using the same imaging paradigm in Tg(npvf:eGFP) control animals 114 
(p<0.01, Mann-Whitney test, 5 animals, 95 neurons) (Figure 2 - figure supplement 1I). Thus, 115 
our stimulation paradigm results in robust ReaChR-dependent activation of npvf-expressing 116 
neurons. 117 
 118 
We next used the same stimulation and imaging paradigm to ask whether optogenetic stimulation 119 
of NPVF neurons results in activation of neurons in the IRa using Tg(npvf:ReaChR-mCitrine); 120 
Tg(tph2:GCaMP6s-tdTomato) animals (Lee et al., 2017; Oikonomou et al., 2019). To do so, we 121 
first recorded baseline GCaMP6s fluorescence in tph2-expressing IRa neurons, then stimulated 122 
npvf-expressing neurons as described above, and then recorded post-stimulation GCaMP6s 123 
fluorescence in IRa neurons (Figure 2A,B). In the frame immediately following optogenetic 124 
stimulation, we observed a 40% increase in GCaMP6s fluorescence in IRa neurons (p<0.0001, 125 
Mann-Whitney test, 4 animals, 154 neurons) that gradually declined to baseline after ~ 40 126 
seconds (Figure 2C, E,F). This extended decay of GCaMP6s fluorescence is consistent with the 127 
prolonged effect expected for neuropeptide/G-protein coupled receptor (GPCR) signaling (van 128 
den Pol, 2012). Notably, while 74% of tph2-expressing neurons displayed an increase in 129 
GCaMP6s fluorescence immediately following stimulation (average ± SEM 𝝙F/F = 63±6%, 116 of 130 
154 neurons), 26% of IRa neurons showed decreased fluorescence (average ± SEM 𝝙F/F = -131 
27±4%, 38 of 154 neurons), demonstrating a heterogeneity in response profiles among IRa 132 
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neurons. These effects were due to optogenetic stimulation of NPVF neurons, as they were not 133 
observed in Tg(npvf:eGFP); Tg(tph2:GCaMP6s-tdTomato) control animals (Figure 2C,D,F). 134 
These results demonstrate that stimulation of NPVF neurons results in activation of serotonergic 135 
IRa neurons, likely via neuropeptide/GPCR signaling. 136 
 137 
Loss of npvf does not enhance the tph2 mutant sleep phenotype 138 
The NPVF prepro-peptide is processed to produce three mature neuropeptides, RFRP 1-3 139 
(Hinuma et al., 2000). We previously generated zebrafish that contain a frameshift mutation within 140 
the npvf gene that is predicted to encode a protein that contains RFRP1 but lacks RFRP2 and 141 
RFRP3 (Lee et al., 2017). We have shown that loss of NPVF signaling due to this mutation (Lee 142 
et al., 2017), or loss of 5-HT production in the RN due to mutation of tph2 (Oikonomou et al., 143 
2019), results in decreased sleep. Based on our observations that NPVF neurons project to and 144 
can stimulate serotonergic IRa neurons (Figure 1,2), we next tested the hypothesis that npvf and 145 
tph2 act in the same genetic pathway to promote sleep. We tested this hypothesis by comparing 146 
the sleep of npvf -/-; tph2 -/- animals to their heterozygous mutant sibling controls (Figure 3). We 147 
reasoned that if npvf and tph2 promote sleep via independent genetic pathways, then animals 148 
lacking both genes should sleep more than either single mutant. In contrast, if npvf and tph2 149 
promote sleep in the same pathway, then loss of both genes should not result in an additive sleep 150 
phenotype. Similar to previous results, animals containing a homozygous mutation in either npvf 151 
or tph2 slept less than heterozygous mutant sibling controls, with tph2 mutants showing a stronger 152 
phenotype (Figure 3B,C,E). However, npvf -/-; tph2 -/- animals did not sleep significantly more 153 
than their npvf +/-; tph2 -/- siblings (Figure 3D,E). Thus, loss of npvf does not enhance the tph2 154 
mutant phenotype, consistent with the hypothesis that tph2 acts downstream of npvf to promote 155 
sleep. 156 
 157 
Sleep induced by stimulation of npvf-expressing neurons requires npvf  158 
.CC-BY 4.0 International licenseIt is made available under a 
perpetuity.preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in 
The copyright holder for this. http://dx.doi.org/10.1101/2019.12.27.889402doi: bioRxiv preprint first posted online Dec. 28, 2019; 
 8 
We previously showed that optogenetic stimulation of NPVF neurons is sufficient to promote sleep 159 
in zebrafish (Lee et al., 2017). However, it is unknown whether this phenotype is due to release 160 
of the NPVF neuropeptide or other factors within these cells, such as the fast neurotransmitter 161 
glutamate (Lee et al., 2017). To directly test the hypothesis that stimulation of npvf-expressing 162 
neurons promotes sleep due to release of NPVF, we optogenetically stimulated these neurons in 163 
npvf mutant animals. Taking advantage of the transparency of zebrafish larvae, we used a 164 
previously described non-invasive, large-scale assay that allows optogenetic stimulation of 165 
specific neuronal populations while monitoring 96 freely-behaving animals (Figure 4 - figure 166 
supplement 1A,B) (Singh et al., 2015). We first recorded baseline behavior for 30 minutes in the 167 
dark, and then exposed the animals to blue light for 30 minutes. Similar to previous results using 168 
animals that are homozygous wild-type for npvf (Lee et al., 2017), optogenetic stimulation of 169 
NPVF neurons in Tg(npvf:ReaChR-mCitrine); npvf +/- animals resulted in reduced locomotor 170 
activity and increased sleep compared to non-transgenic npvf +/- sibling controls (Figure 4 - 171 
figure supplement 1C). In contrast, there was no significant difference between the behavior of 172 
Tg(npvf:ReaChR-mCitrine); npvf -/- animals and their non-transgenic npvf -/- siblings (Figure 4 - 173 
figure supplement 1D). This result indicates that sleep induced by stimulation of NPVF neurons 174 
requires NPVF, and thus acts via NPVF neuropeptide/GPCR signaling. 175 
 176 
Sleep induced by optogenetic stimulation of npvf-expressing neurons requires 177 
serotonergic RN neurons 178 
We next asked whether there is a functional interaction between npvf-expressing neurons and 179 
the RN in promoting sleep by testing the hypothesis that NPVF neuron-induced sleep requires 180 
serotonergic RN neurons. To do so, we optogenetically stimulated npvf-expressing neurons in 181 
animals where the RN was chemogenetically ablated by enhanced nitroreductase (eNTR) 182 
(Mathias et al., 2014; Tabor et al., 2014). eNTR converts the inert pro-drug metronidazole (MTZ) 183 
into a cytotoxic compound that causes cell-autonomous death (Curado et al., 2007). We 184 
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previously showed using Tg(tph2:eNTR-mYFP) animals, which express eNTR-mYFP in 185 
serotonergic RN neurons, that ablation of these neurons results in decreased sleep (Oikonomou 186 
et al., 2019). This phenotype is similar to those of both tph2 -/- zebrafish and to mice in which the 187 
dorsal and median serotonergic RN are ablated (Oikonomou et al., 2019). To ask whether NPVF 188 
neuron-induced sleep requires the RN, we generated Tg(npvf:ReaChR-mCitrine); Tg(tph2:eNTR-189 
mYFP) animals and asked whether the sedating effect of stimulating NPVF neurons is diminished 190 
in RN ablated animals (Figure 4A,B). Similar to our previous report (Oikonomou et al., 2019), 191 
treatment of these animals with 5 mM MTZ during 2-4 dpf resulted in near complete loss of YFP 192 
fluorescence and 5-HT immunoreactivity in the RN (Figure 4E,F). In contrast, treatment of these 193 
animals with DMSO vehicle control (Figure 4C,D), or treatment of Tg(tph2:eNTR-mYFP) negative 194 
siblings with MTZ (Figure 4G,H), did not cause loss of the RN. We found that optogenetic 195 
stimulation of MTZ-treated Tg(npvf:ReaChR-mCitrine) animals resulted in increased locomotor 196 
activity and decreased sleep compared to identically treated non-transgenic siblings (Figure 4I), 197 
indicating that MTZ treatment does not itself block NPVF neuron-induced sleep. In contrast, there 198 
was no significant difference in the behavior of MTZ-treated Tg(npvf:ReaChR-mCitrine); 199 
Tg(tph2:eNTR-mYFP) animals compared to their Tg(tph2:eNTR-mYFP) siblings (Figure 4J). 200 
These results indicate that the sedating effect of stimulating npvf-expressing neurons requires the 201 
serotonergic RN. 202 
 203 
Sleep induced by stimulation of npvf-expressing neurons requires serotonin in RN 204 
neurons 205 
Zebrafish RN neurons produce not only serotonin, but also other factors such as GABA 206 
(Kawashima et al., 2016) that may mediate NPVF neuron-induced sleep. To distinguish between 207 
these possibilities, we next tested the hypothesis that NPVF neuron-induced sleep requires the 208 
presence of serotonin in RN neurons. To do so, we compared the effect of optogenetic stimulation 209 
of npvf-expressing neurons in tph2 -/- animals, which do not synthesize serotonin in RN neurons 210 
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(Oikonomou et al., 2019), to tph2 +/- sibling controls. Similar to previous results (Lee et al., 2017), 211 
stimulation of npvf-expressing neurons in Tg(npvf:ReaChR-mCitrine); tph2 +/- animals resulted 212 
in decreased locomotor activity and increased sleep (Figure 4 - figure supplement 1E). In 213 
contrast, there was no significant difference between the behavior of Tg(npvf:ReaChR-mCitrine); 214 
tph2 -/- animals and their non-transgenic tph2 -/- siblings (Figure 4 - figure supplement 1F), 215 
consistent with the hypothesis that NPVF neuron-induced sleep requires serotonin in RN neurons. 216 
 217 
As additional confirmation that NPVF neuron-induced sleep requires serotonin in RN neurons, we 218 
compared the effect of chemogenetic stimulation of npvf-expressing neurons in tph2 -/- animals 219 
to tph2 +/- sibling controls (Figure 4 – figure supplement 2). To do so, we expressed the rat 220 
capsaicin receptor TRPV1 in NPVF neurons using Tg(npvf:KalTA4); Tg(UAS:TRPV1-tagRFP-T) 221 
animals (Lee et al., 2017). We previously showed that treating these animals with 2 μM capsaicin, 222 
a TRPV1 small molecule agonist, results in activation of NPVF neurons and increased sleep at 223 
night (Lee et al., 2017). Consistent our previous observations, capsaicin-treated Tg(npvf:KalTA4); 224 
Tg(UAS:TRPV1-tagRFP-T); tph2 +/- animals slept more at night than their capsaicin-treated 225 
Tg(npvf:KalTA4); tph2 +/- siblings (Figure 4 – figure supplement 2C,F), indicating that 226 
chemogenetic activation of NPVF neurons results in increased sleep at night in animals that 227 
produce serotonin in the RN. However, there was no significant difference in sleep at night 228 
between capsaicin-treated Tg(npvf:KalTA4); Tg(UAS:TRPV1-tagRFP-T); tph2 -/- animals and 229 
their capsaicin-treated Tg(npvf:KalTA4); tph2 -/- siblings (Figure 4 – figure supplement 2D,F). 230 
This result is consistent with the hypothesis that NPVF neuron-induced sleep requires serotonin 231 
in RN neurons. Since 5-HT is not present in NPVF neurons (Figure 1B-D), our optogenetic and 232 
chemogenetic data indicate that NPVF neuron-induced sleep requires serotonin in RN neurons. 233 
 234 
DISCUSSION 235 
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The serotonergic RN were first implicated in sleep-wake regulation over 50 years ago, but it has 236 
long been disputed whether they act to promote sleep or wakefulness (Ursin, 2008). We and 237 
others recently addressed this controversy in both mammals and zebrafish by providing both gain- 238 
and loss-of-function evidence using genetic, pharmacological, optogenetic and chemogenetic 239 
approaches to demonstrate that the serotonergic RN promote sleep (Oikonomou et al., 2019; 240 
Venner et al., 2019). This finding agrees with invertebrate studies which showed that 5-HT 241 
signaling promotes sleep in Drosophila (Qian et al., 2017; Yuan et al., 2006). However, while 5-242 
HT plays an evolutionarily conserved role in promoting sleep, the neuronal mechanism that acts 243 
upon serotonergic neurons to promote sleep was unknown. Here we show that npvf-expressing 244 
neurons in the dorsomedial hypothalamus, which we previously found to be sleep-promoting in 245 
zebrafish (Lee et al., 2017), densely innervate the rostral IRa, can stimulate serotonergic IRa 246 
neurons, and require 5-HT in RN neurons in order to induce sleep. These results describe a 247 
simple hypothalamic-hindbrain sleep-promoting neuronal circuit arising from the dorsomedial 248 
hypothalamus, a region previously linked to circadian regulation of wakefulness (Chou et al., 249 
2003; Gooley et al., 2006; Mieda et al., 2006), but not to sleep. This finding suggests that re-250 
examination of hypothalamic populations using the modern tools of neuroscience may reveal 251 
additional sleep- and wake-promoting populations.  252 
 253 
We observed that stimulation of NPVF neurons results in increased GCaMP6s fluorescence in 254 
most serotonergic IRa neurons, although a significant minority of IRa neurons show reduced 255 
GCaMP6s fluorescence. These observations suggest that there are at least two functionally 256 
distinct neuronal populations among tph2-expressing IRa neurons, consistent with studies of the 257 
mammalian RN that identified molecularly distinct sub-populations with distinct efferent projection 258 
patterns and functions (Huang et al., 2019; Ren et al., 2018; Ren et al., 2019). The NPVF neuron-259 
induced inhibition of a sub-population of IRa neurons that we observed is consistent with a 260 
previous study which reported that optogenetic stimulation of NPVF neurons resulted in 261 
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decreased GCaMP6s fluorescence in IRa neurons (Madelaine et al., 2017), although the effect 262 
was small and slow compared to our data. Further studies are needed to explore the molecular 263 
and functional diversity of RN neurons in zebrafish. 264 
 265 
The hypothalamic-hindbrain neuronal circuit that we have described can be integrated into a 266 
larger sleep-promoting network. We recently reported that epidermal growth factor receptor 267 
(EGFR) signaling is necessary and sufficient for normal sleep amounts in zebrafish, and that it 268 
promotes sleep, in part, via the NPVF system (Lee et al., 2019). We found that it does so by both 269 
promoting the expression of npvf and by stimulating npvf-expressing neurons. The EGFR ligands 270 
egf and transforming growth factor alpha are expressed in glial cells in the dorsal diencephalon, 271 
and egfra, the EGFR paralog that is primarily responsible for the role of EGFR signaling in sleep, 272 
is expressed in juxta-ventricular glial cells found along the hypothalamus, hindbrain, tectum and 273 
cerebellum. Taken together with the current study, these results describe a genetic and neuronal 274 
circuit spanning EGFR signaling components in glial cells, npvf-expressing neurons in the 275 
hypothalamus, and serotonergic RN neurons in the hindbrain.  276 
 277 
If the EGFR-NPVF-RN sleep-promoting circuit plays a central and important role in regulating 278 
sleep, one might expect it to be evolutionarily conserved. Indeed, similar to zebrafish, EGFR 279 
signaling promotes sleep in C. elegans and Drosophila (Donlea et al., 2009; Foltenyi et al., 2007; 280 
Van Buskirk and Sternberg, 2007), and genetic experiments suggest that it does so in part via 281 
RFamide neuropeptides that may be invertebrate homologs of npvf (He et al., 2013; Iannacone 282 
et al., 2017; Lenz et al., 2015; Nagy et al., 2014; Nath et al., 2016; Nelson et al., 2014; Shang et 283 
al., 2013; Turek et al., 2016). Serotonin has also been shown to promote sleep in Drosophila 284 
(Qian et al., 2017; Yuan et al., 2006), and by analogy to our results, we hypothesize that RFamide 285 
neuropeptides such as FMRFamide (Lenz et al., 2015) may act upstream of 5-HT to promote 286 
Drosophila sleep. The role of EGFR signaling in mammalian sleep is less clear. 287 
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Intracerebroventricular injection of epidermal growth factor (EGF) in rabbits was sufficient to 288 
increase sleep (Kushikata et al., 1998), and mice containing linked mutations in Egfr and Wnt3a 289 
(Wingless integration site 3a) showed abnormal circadian timing of sleep (Kramer et al., 2001). 290 
Furthermore, pharmacological inhibition or mutation of extracellular regulated kinase (ERK), 291 
which mediates EGFR signaling, was shown to result in reduced sleep in mice (Mikhail et al., 292 
2017). The spatial expression of NPVF neurons within the hypothalamus is highly conserved 293 
between humans, rodents, and zebrafish (Lee et al., 2017; Liu et al., 2001; Ubuka et al., 2009; 294 
Yelin-Bekerman et al., 2015), as are the expression of EGFR and its ligands in zebrafish and 295 
rodent brains (Lee et al., 2019; Ma et al., 1994; Ma et al., 1992). However, NPVF has not been 296 
studied in the context of mammalian sleep, so further studies are required to determine whether 297 
the EGFR/NPVF/RN circuit described in zebrafish is conserved in mammals. 298 
 299 
 300 
 301 
 302 
 303 
 304 
 305 
 306 
 307 
 308 
 309 
 310 
 311 
 312 
 313 
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MATERIALS AND METHODS 314 
KEY RESOURCE TABLE 315 
REAGENT 
TYPE or 
RESOURCE 
Designation SOURCE OR REFERENCE IDENTIFIERs 
ADDITIONAL 
INFORMATION 
antibody Rabbit polyclonal anti-5-HT antibody MilliporeSigma Cat# S5545; 
RRID:AB_477522 
1:1000 
antibody Chicken anti-GFP Aves Laboratory Cat# GFP-1020, 
RRID:AB_10000240 
1:1000 
antibody Rabbit anti-DsRed Takara Bio Cat# 632496, 
RRID:AB_10013483 
1:1000 
antibody Rabbit anti-tagRFP Evrogen Cat# AB233, 
RRID:AB_2571743 
1:200 
antibody Goat anti-Chicken IgY (H+L) Secondary 
Antibody, Alexa Fluor 488 
ThermoFisher Sci. Cat# A-11039;  
RRID: AB_2534096 
1:500 
antibody Goat anti-Rabbit IgG (H+L) Cross-
Adsorbed Secondary Antibody, Alexa Fluor 
568 
ThermoFisher Sci. Cat# A-11011;  
RRID: AB_143157 
1:500 
antibody Goat anti-Rat IgG (H+L) Cross-Adsorbed 
Secondary Antibody, Alexa Fluor 488 
ThermoFisher Sci. Cat# A-11006, 
RRID:AB_2534074 
1:500 
chemical 
compound, 
drug  
Metronidazole MP Biomedicals Cat# 0215571080  
chemical 
compound, 
drug 
16% paraformaldehyde ThermoFisher Sci. Cat# 15710  
chemical 
compound, 
drug 
Normal goat serum ThermoFisher Sci. Cat# NC9660079  
chemical 
compound, 
drug 
Collagenase MilliporeSigma Cat# C9891  
chemical 
compound, 
drug 
Vectashield Vector laboratories Cat# H-1000; 
RRID:AB_2336789 
 
genetic reagent 
(D. rerio)  
Zebrafish: npvf ct845 mutant (Lee et al., 2017) RRID: ZDB-ALT-
170927-1 
 
genetic reagent 
(D. rerio) 
Zebrafish: tph2 ct817 mutant (Chen et al., 2013a) RRID: ZDB-ALT-
131122-14 
 
genetic reagent 
(D. rerio) 
Zebrafish: Tg(npvf:eGFP) ct847Tg  (Lee et al., 2017) RRID: ZDB-ALT-
170927-3 
 
genetic reagent 
(D. rerio) 
Zebrafish: Tg(npvf:GCaMP6s-tdTomato) 
ct872Tg 
(Lee et al., 2019) ZFIN: ZDB-ALT-
190725-5 
 
genetic reagent 
(D. rerio) 
Zebrafish: Tg(npvf:ReaChR-mCitrine) 
ct849Tg 
(Lee et al., 2017) RRID: ZDB-ALT-
170927-5 
 
genetic reagent 
(D. rerio) 
Zebrafish: Tg(npvf:kalta4) ct848Tg (Lee et al., 2017) RRID: ZDB-ALT-
170927-4 
 
genetic reagent 
(D. rerio) 
Zebrafish: Tg(tph2:eNTR-mYFP) ct866Tg (Oikonomou et al., 
2019) 
RRID: ZDB-ALT-
190508-3  
 
genetic reagent 
(D. rerio) 
Zebrafish: Tg(tph2:GCaMP6s-tdTomato)  This study   
genetic reagent 
(D. rerio) 
Zebrafish: Tg(UAS:nfsb-mCherry) 
rw0144Tg 
(Agetsuma et al., 
2010) 
ZFIN: ZDB-ALT-
110215-7 
 
genetic reagent 
(D. rerio) 
Zebrafish: Tg(UAS:TRPV1-tagRFP-T) 
ct851Tg 
(Lee et al., 2017) RRID: ZDB-ALT-
170927-7 
 
sequence-
based reagent  
Primer: tph2 mutant genotyping primer 1: 
AGAACTTACAAAACTCTATCCAACTC 
(Oikonomou et al., 
2019) 
N/A  
sequence-
based reagent 
Primer: tph2 mutant genotyping primer 2: 
AGAGAGGACAACATCTGGGG 
(Oikonomou et al., 
2019) 
N/A  
sequence-
based reagent 
Primer: tph2 mutant genotyping primer 3: 
TAATCATGCAGTCCGTTAATACTC 
(Oikonomou et al., 
2019) 
N/A  
sequence-
based reagent 
Primer: npvf mutant genotyping primer 1: 
CAGTGGTGGTGCGAGTTCT  
(Lee et al., 2017) N/A  
sequence-
based reagent 
Primer: npvf mutant genotyping primer 2: 
GCTGAGGGAGGTTGATGGTA  
(Lee et al., 2017) N/A  
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sequence-
based reagent 
Primer: Tg(npvf:ReaChR-mCitrine) 
genotyping primer 1: 
CACGAGAGAATGCTGTTCCA 
(Lee et al., 2017) N/A  
sequence-
based reagent 
Primer: Tg(npvf:ReaChR-mCitrine) 
genotyping primer 2: 
CCATGGTGCGTTTGCTATAA  
(Lee et al., 2017) N/A  
sequence-
based reagent 
Primer: Tg(UAS:TRPV1-tagRFP-T) 
genotyping primer 1: 
CAGCCTCACTTTGAGCTCCT:  
(Lee et al., 2017) N/A  
sequence-
based reagent 
Primer: Tg(UAS:TRPV1-tagRFP-T) 
genotyping primer 2: 
TCCTCATAAGGGCAGTCCAG 
(Lee et al., 2017) N/A  
software MATLAB R2017b Mathworks RRID:SCR_001622  
software Prism6 GraphPad RRID:SCR_002798  
software Image J/Fiji (Schneider et al., 
2012) 
RRID:SCR_002285  
other  96-well plate  GE Healthcare Life 
Sciences 
Cat#:7701-1651  
other MicroAmp Optical Adhesive Film Thermo Fisher 
Scientific 
Cat#: 4311971  
 316 
 317 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 318 
Animal husbandry and all experimental procedures involving zebrafish were performed in 319 
accordance with the California Institute of Technology Institutional Animal Care and Use 320 
Committee (IACUC) guidelines and by the Office of Laboratory Animal Resources at the California 321 
Institute of Technology (animal protocol 1580). All experiments used zebrafish between 5 and 6 322 
dpf. Sex is not yet defined at this stage of development. Larvae were housed in petri dishes with 323 
50 animals per dish. E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4) 324 
was used for housing and experiments. All lines were derived from the TLAB hybrid strain. Unless 325 
otherwise indicated, for experiments using mutant animals, heterozygous and homozygous 326 
mutant adult animals were mated, and their homozygous mutant and heterozygous mutant 327 
progeny were compared to each other to minimize variation due to genetic background. For 328 
experiments using transgenic animals, heterozygous transgenic animals were outcrossed to non-329 
transgenic animals of the parental TLAB strain, and transgenic heterozygote progeny were 330 
compared to their non-transgenic siblings. Behavioral experiments were performed unbiased to 331 
genotype, with animals genotyped by PCR after each experiment was complete. 332 
 333 
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Transgenic and mutant animals 334 
The Tg(npvf:eGFP) ct847Tg (Lee et al., 2017), Tg(npvf:ReaChR-mCitrine) ct849Tg (Lee et al., 335 
2017), Tg(npvf:kalta4) ct848Tg (Lee et al., 2017), Tg(tph2:eNTR-mYFP) ct866Tg (Oikonomou et 336 
al., 2019), Tg(UAS:nfsb-mCherry) rw0144Tg (Agetsuma et al., 2010), Tg(UAS:TRPV1-tagRFP-337 
T) ct851Tg (Lee et al., 2017), npvf ct845 mutant (Lee et al., 2017), and tph2 ct817 mutant (Chen 338 
et al., 2013a) lines have been previously described. 339 
 340 
To generate the Tg(tph2:GCaMP6s-P2A-NLS-tdTomato) line we cloned the tph2 promoter 341 
(Oikonomou et al., 2019) upstream of GCaMP6s (Chen et al., 2013b) followed by a P2A 342 
sequence, which generates a self-cleaving peptide (Kim et al., 2011), and NLS-tdTomato. Stable 343 
transgenic lines were generated using the Tol2 method (Urasaki et al., 2006). 344 
 345 
Immunohistochemistry 346 
Samples were fixed in 4% PFA/4% sucrose in PBS overnight at 4oC and then washed with 0.25% 347 
Triton X-100/PBS (PBTx). Immunolabeling was performed using dissected brains because this 348 
allows for superior antibody penetration. Dissected brains were incubated for 1 hour in 1 mg/mL 349 
collagenase (C9891, MilliporeSigma, St. Louis, Missouri, USA) and blocked overnight in 2% 350 
NGS/2% DMSO in PBTx at 4oC. Incubation with rabbit anti-5-HT (1:1000; S5545, MilliporeSigma, 351 
Burlington, MA, USA), chicken anti-GFP (1:1000, GFP-1020, Aves Laboratory, Davis, CA, USA), 352 
and rabbit anti-DsRed (1:1000, Takara Bio, Mountainview, CA, USA) primary antibodies was 353 
performed in blocking solution overnight at 4oC. Incubation with goat anti-rabbit IgG Alexa Fluor 354 
568, goat anti-chicken IgY Alexa Fluor 488, and goat anti-rat IgG Alexa Fluor 488 (all 1:500, 355 
ThermoFisher Sci., Waltham, MA, USA) secondary antibodies was performed in blocking solution 356 
overnight at 4oC. Samples were mounted in Vectashield (H-1000; Vector Laboratories, 357 
Burlingame, CA, USA) and imaged using a Zeiss LSM 880 confocal microscope (Zeiss, 358 
Oberkochen, Germany). 359 
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 360 
Two-photon optogenetic stimulation and GCaMP6s imaging 361 
At 6 dpf, animals were paralyzed by immersion in 1 mg/ml α-bungarotoxin (2133, Tocris, Bristol, 362 
UK) dissolved in E3, embedded in 1.5% low melting agarose (EC-202, National Diagnostics, 363 
Atlanta, GA, United States) and imaged using a 20x water immersion objective on a Zeiss LSM 364 
880 microscope equipped with a two-photon laser (Chameleon Coherent, Wilsonville, OR, USA). 365 
Laser power coming out of the objective was quantified using a power meter (PM121D, ThorLabs, 366 
Newton, NJ, USA). For GCaMP6s imaging, a region of interest (ROI) that encompassed the npvf- 367 
or tph2-expressing neuronal somas was defined based on nuclear localized tdTomato, which was 368 
stoichiometrically co-expressed with GCaMP6s. GCaMP6s fluorescence intensity was quantified 369 
using Image J (Schneider et al., 2012). Figure 2 – figure supplement 1F provides an example 370 
of how ROI were defined. GCaMP6s fluorescence was excited using a 920 nm two-photon laser 371 
(Chameleon Coherent, Wilsonville, OR, USA) at 8 mW, imaged in a 512 x 256 pixel frame (1.27 372 
s per frame, pixel size=0.55 µm, pixel dwell time=2.07 µs) for 150 frames (190.5 s). For 373 
optogenetic stimulation of NPVF neurons, a 150 x 100 pixel region that encompassed the NPVF 374 
neuronal somas was illuminated using the 920 nm two-photon laser at 38 mW. Ten pulses were 375 
applied over 3.72 s using the bleaching function at 2.7 Hz per pixel. The time between the final 376 
stimulation pulse and initiation of post-stimulation imaging was 0.6 s, and was due to the computer 377 
registering coordinate information with the scan device (~0.4 s) and for the non-descanned 378 
detector to turn off (~0.2 s). GCaMP6s fluorescence was then imaged again for another 150 379 
frames before another stimulation trial. Three stimulation trials were performed on each fish, and 380 
the average value from these trials was calculated for each neuron. Baseline fluorescence (F0) 381 
for each trial was defined as the average value from 30 frames immediately preceding the 382 
stimulation, and 35 (Figure 2D-F) or 30 (Figure 2 – figure supplement 1G-I) frames post 383 
stimulation were used to measure the normalized change in fluorescence (ΔF/F = (F−F0)/(F0 − 384 
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Fbackground). Fbackground was defined by average fluorescence intensity during 30 frames prior to 385 
optogenetic stimulation in a GCaMP-negative background region approximately 40 μm from the 386 
nearest NPVF neuronal soma. Five Tg(npvf:ReaChR);Tg(npvf:GCaMP6s-tdTomato) animals, 387 
with approximately 17 NPVF neurons per animal, were analyzed for Figure 2 – figure 388 
supplement 1. Data from four Tg(npvf:ReaChR);Tg(tph2:GCaMP6s-tdTomato) and four 389 
Tg(npvf:eGFP);Tg(tph2:GCaMP6s-tdTomato) animals, with approximately 30 IRa neurons 390 
analyzed per animal, is shown in Figure 2 – figure supplement 1. 391 
 392 
Sleep/wake behavioral analysis 393 
Sleep/wake analysis was performed as previously described (Chiu et al., 2016). Larvae were 394 
raised on a 14:10 h light:dark (LD) cycle at 28.5oC with lights on at 9 a.m. and off at 11 p.m. Dim 395 
white light was used to raise larvae for optogenetic experiments to prevent stimulation of ReaChR 396 
by ambient light. Individual larvae were placed into each well of a 96-well plate (7701-1651, 397 
Whatman, Pittsburgh, PA, United States) containing 650 μl of E3 embryo medium. Locomotor 398 
activity was monitored using a videotracking system (Viewpoint Life Sciences, Lyon, France) with 399 
a Dinion one-third inch Monochrome camera (Dragonfly 2, Point Grey, Richmond, Canada) fitted 400 
with a variable-focus megapixel lens (M5018-MP, Computar, Cary, NC, United States) and 401 
infrared filter. The movement of each larva was recorded using the quantization mode. The 96-402 
well plate and camera were housed inside a custom-modified Zebrabox (Viewpoint Life Sciences) 403 
that was continuously illuminated with infrared light. The 96-well plate was housed in a chamber 404 
filled with recirculating water to maintain a constant temperature of 28.5oC. The parameters used 405 
for movement detection were: detection threshold, 15; burst, 29; freeze, 3; bin size, 60 s, which 406 
were determined empirically. Data were analyzed using custom Perl and Matlab (Mathworks, 407 
Natick, MA, United States) scripts, which conform to the open source definition. 408 
 409 
Optogenetic stimulation of freely behaving animals 410 
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Optogenetic behavioral experiments were performed as described (Singh et al., 2015). These 411 
experiments used a videotracking system with a custom array containing three sets of blue LEDs 412 
(470 nm, MR-B0040-10S, Luxeon V-star, Brantford, Canada) mounted 15 cm above and 7 cm 413 
away from the center of the 96-well plate to ensure uniform illumination. The LEDs were controlled 414 
using a custom-built driver and software written in BASIC stamp editor. A power meter (1098293, 415 
Laser-check, Santa Clara, CA, USA) was used before each experiment to verify uniform light 416 
intensity (∼400 μW at the surface of the 96-well plate). In the afternoon of the fifth day of 417 
development, single larvae were placed into each well of a 96-well plate and placed in the 418 
videotracker in the dark. Larvae were exposed to blue light for 30 minutes for each of 3 trials 419 
beginning at 12:30 am, 3:00 am, 5:30 am. Behavior was monitored for 30 minutes before and 420 
after light onset. Light onset induces a startle response, which causes a short burst of locomotor 421 
activity. For this reason, we excluded five minutes of behavioral recording centered at the peak 422 
of blue light onset from analysis. Data was normalized by dividing the locomotor activity or sleep 423 
of each animal during light exposure by the average baseline locomotor activity or sleep of all 424 
animals of the same genotype. For baseline, we used a time period equal in length to blue light 425 
exposure, but prior to light onset. 426 
 427 
Chemogenetic ablation 428 
Animals were treated with 5 mM metronidazole (MTZ) (0215571080, MP Biomedicals, Santa Ana, 429 
CA, USA) diluted in E3 medium containing 0.1% DMSO, starting in the afternoon at 2 dpf, and 430 
refreshed every 24 hours. Animals were kept in dim light during the day to prevent MTZ 431 
photodegradation. On the evening at 4-dpf, the animals were rinsed 3 times in E3 medium, moved 432 
into petri dishes to allow for recovery overnight, and then transferred to 96-well plates on the 433 
morning of 5-dpf. Reported data is from the 5th night of development. 434 
 435 
Chemogenetic stimulation 436 
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Neuronal activation using TRPV1 was performed as described (Lee et al., 2017) with some 437 
modifications. Tg(npvf:KalTA4); tph2+/-, Tg(npvf:KalTA4); tph2-/-, Tg(npvf:KalTA4); 438 
Tg(UAS:TRPV1-tagRFP-T); tph2+/-, and Tg(npvf:KalTA4);Tg(UAS:TRPV1-tagRFP-T); tph2-/- 439 
siblings were immersed in 2 μM capsaicin at ~100 h post-fertilization (hpf). Capsaicin powder 440 
(M2028, Sigma, St. Louis, Missouri, USA) was dissolved in DMSO to prepare a 100 mM stock 441 
solution that was stored in aliquots at -20 ̊C. Capsaicin working solutions were prepared just 442 
before each experiment by diluting the stock solution in E3 medium. All treatments contained a 443 
final concentration of 0.002% DMSO. Behavioral analysis was performed from 5 dpf until 6 dpf 444 
blinded to the genotype. 445 
 446 
QUANTIFICATION AND STATISTICAL ANALYSIS  447 
For all behavioral experiments the unit of analysis for statistics is a single animal. For optogenetic 448 
imaging experiments, the unit of analysis for statistics is the average of three optogenetic 449 
stimulation trials for a single neuron. The number of neurons and animals whose data are shown 450 
in a panel are either shown in the figure or stated in the figure legend. Line graphs in Figure 3A-451 
D and Figure 4 – figure supplement 2A-D represent mean, and were generated from raw data 452 
that was smoothed over 1 hour bins in 10 minute intervals. The significance threshold was set to 453 
P<0.05, and P values were adjusted for multiple comparisons where appropriate. Normality tests 454 
(D’Agostino & Pearson omnibus normality test) found that most datasets were not normally 455 
distributed so we used non-parametric tests for statistical analyses (Mann-Whitney test for two 456 
unpaired groups). For comparison of differences between groups with two-factor designs, we 457 
used Two-Way ANOVA with Holm-Sidak correction for multiple comparisons (Figure 3,4). 458 
Normality tests (D’Agostino & Pearson omnibus normality test) for the data in Figures 3 and 459 
Figure 4 – figure supplement 2 demonstrated that half of values were normally distributed, 460 
suggesting that Two-Way ANOVA would be an appropriate statistical test; ANOVA analyses are 461 
robust to even large deviation from normality when samples sizes are appropriately large enough. 462 
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For box plots, the box extends from the 25th to the 75th percentile with the median marked by a 463 
horizontal line through the box. The lower and upper whiskers extend to the 10th and 90th 464 
percentile, respectively. Data points outside the lower and upper whiskers were not shown in the 465 
graphs to facilitate data presentation but were included in statistical analyses. Statistical analyses 466 
were performed using Prism 6 (GraphPad Software, San Diego, CA, USA).  467 
 468 
DATA AND CODE AVAILABILITY 469 
Source code data used to generate most figures are publicly available at 470 
https://elifesciences.org/articles/25727 (Lee et al., 2017). All input data used to generate most 471 
figures is available as source data associated with this manuscript.  472 
 473 
Figure 1-Source Data 1: Confocal stack of a brain from a 6-dpf Tg(npvf:eGFP) animal 474 
immunostained against eGFP and 5-HT.  475 
 476 
Figure 1-Supplement1-Source Data 1: Confocal stacks of a brain from a 6-dpf 477 
Tg(npvf:KalTA4);Tg(uas:nfsb-mCherry);Tg(tph2:eNTR-mYFP) animal immunostained against 478 
YFP and mCherry.  479 
 480 
Figure 2-Source Data 1: (A) Confocal image of a live 6-dpf Tg(npvf:ReaChR-mCitrine); 481 
Tg(tph2:GCaMP6s-tdTomato) animal showing GCaMP6s and tdTomato fluorescence in IRa 482 
neurons. Green and magenta fluorescence in the eyes is due to autofluorescence. (C) Average 483 
GCaMP6s fluorescence in IRa neurons for 10 frames before (Pre) and after (Post) optogenetic 484 
stimulation of NPVF neurons. (D,E) Input data and statistical analysis for GCaMP6s fluorescence 485 
of IRa neurons plotted as a function of time, showing pre-stimulation and post-stimulation evoked 486 
responses for Tg(tph2:GCaMP6s-tdTomato) animals that also contain a Tg(npvf:eGFP) (D,F) or 487 
Tg(npvf:ReaChR-mCitrine). 488 
.CC-BY 4.0 International licenseIt is made available under a 
perpetuity.preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in 
The copyright holder for this. http://dx.doi.org/10.1101/2019.12.27.889402doi: bioRxiv preprint first posted online Dec. 28, 2019; 
 22 
 489 
Figure 2-Supplement1-Source Data 1: (A) Confocal image of a live 6-dpf Tg(npvf:ReaChR); 490 
Tg(npvf:GCaMP6s-tdTomato) animal showing GCaMP6s and tdTomato fluorescence in NPVF 491 
neurons. Green and magenta fluorescence in the eyes is due to autofluorescence. (H) GCaMP6s 492 
and mCitrine 𝝙F/F values for individual NPVF neurons (86 neurons, 5 animals) are plotted as 493 
function of time, showing pre-stimulation and post-stimulation evoked responses. (I) Statistical 494 
analysis for GCaMP6s and mCitrine 𝝙F/F values one frame after stimulation for 495 
Tg(npvf:GCaMP6s-tdTomato) animals that also contain a Tg(npvf:ReaChR) (blue) or 496 
Tg(npvf:eGFP) (black) transgene. n=number of neurons. 497 
 498 
Figure 3-Source Data 1: Input data and statistical analysis for the average sleep for npvf +/-; 499 
tph2 +/-, npvf -/-; tph2 +/-, npvf +/-; tph2 -/-, and npvf -/-; tph2 -/- siblings. 500 
 501 
Figure 4-Source Data 1: (B) Confocal image of an immunostained 5-dpf Tg(tph2:eNTR-mYFP) 502 
zebrafish brain showing serotonergic RN neurons and some of their projections and labeled with 503 
a 5-HT specific antibody. (I-J) Input data and statistical analysis for normalized locomotor activity 504 
and sleep of 5-dpf Tg(npvf:ReaChR) and non-transgenic sibling controls (black and gray) 505 
zebrafish before (Baseline) and during blue light exposure (Stimulation) in Tg(tph2:eNTR) 506 
negative animals (I) and in Tg(tph2:eNTR) positive siblings (J). Box plots quantify locomotor 507 
activity and sleep during optogenetic stimulation normalized to baseline of the same genotype. 508 
n=number of animals. 509 
 510 
Figure 4-Supplement1-Source Data 1: (A) Confocal image of a live 5-dpf Tg(npvf:ReaChR-511 
mCitrine) animal. NPVF neurons in the hypothalamus are labeled with the npvf:ReaChR-mCitrine 512 
transgene. Green fluorescence in the eyes is due to autofluorescence. (C,D) Input data and 513 
statistical analysis for normalized locomotor activity and sleep of Tg(npvf:ReaChR) and non-514 
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transgenic sibling control animals before (Baseline) and during exposure to blue light (Stimulation) 515 
in npvf +/- (C) and npvf -/- (D) animals. (E,F) Same as (C,D) but with tph2 mutant rather than npvf 516 
mutant. Because the animals see the blue light, they exhibit a brief startle at light onset that is 517 
excluded from analysis, followed by a gradual increase in activity that plateaus after ~15 minutes. 518 
Box plots quantify locomotor activity and sleep for each animal during optogenetic stimulation 519 
normalized to the baseline of all animals the same genotype. Stimulation of npvf-expressing 520 
neurons decreases locomotor activity and increases sleep compared to non-transgenic sibling 521 
controls in npvf +/- animals (C) but not in npvf -/- siblings (D), and in tph2 +/- animals (E) but not 522 
in tph2 -/- siblings (F). n=number of animals. 523 
 524 
Figure 4-Supplement2-Source Data 2: (A) Input data and statistical analysis for sleep 525 
associated with 5-6dpf Tg(npvf:KalTA4); tph2+/-, Tg(npvf:KalTA4);tph2-/-, 526 
Tg(npvf:KalTA4);Tg(UAS:TRPV1-TagRFP-T);tph2+/-, and Tg(npvf:KalTA4);Tg(UAS:TRPV1-527 
TagRFP-T);tph2-/- (light blue) siblings treated with 2 μM capsaicin. 528 
 529 
 530 
 531 
 532 
 533 
 534 
 535 
 536 
 537 
 538 
 539 
 540 
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Figure 1. Hypothalamic NPVF neurons project to the serotonergic IRa
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Figure 1. Hypothalamic NPVF neurons project to the serotonergic IRa. (A,E)
Schematic 6-dpf zebrafish brain showing location of hypothalamic (Hy) NPVF neurons
(green), and the serotonergic SRa (red) and IRa (magenta). a, anterior; p, posterior; d,
dorsal. (B-D) Maximum intensity projection of a brain from a 6-dpf Tg(npvf:eGFP) animal
(78 µm thick). npvf-expressing neurons in the hypothalamus project to the serotonergic
raphe nuclei (RN) in the hindbrain (bracket). 5-HT immunohistochemistry labels the RN
(bracket), as well as serotonergic populations in the ventral hypothalamus (asterisks) and
pretectum. The bracketed region in (B-D) is shown at higher magnification in (I-K) as a
maximum intensity projection (50.5 µm thick), with a sagittal view shown in (E-H). Single
optical sections are shown in Figure S1. Scale: 50 µm (B-D), 20 µm (F-H) and 10 µm (I-K).
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Figure 1 – figure supplement 1. Projections of hypothalamic NPVF neurons 
to the serotonergic IRa shown in single optical sections. 
Figure 1 – figure supplement 1. Projections of hypothalamic NPVF neurons to the serotonergic
IRa shown in single optical sections. Related to Figure 1. (A,B) Serial optical sections (0.5 µm thick)
in the hindbrain of a 6-dpf Tg(npvf:eGFP) animal labeled with a 5-HT-specific antibody (magenta), which
were used to generate the image shown in Figure 1K. Fibers from npvf-expressing neurons (green) do
not innervate SRa soma (A) but do innervate IRa soma (B). (C) A 4 µm thick optical section of a brain
from a 6-dpf Tg(npvf:KalTA4); Tg(uas:nfsb-mCherry); Tg(tph2:eNTR-mYFP) animal. White bracket
indicates the IRa and is magnified in panels (D,E), which show 0.6 µm thick serial optical sections.
Fibers from npvf-expressing neurons (magenta) do not innervate SRa neurons (green, D) but do
innervate IRa neurons and their fibers (green, E). Hyp, hypothalamus, IRa, inferior raphe; D, dorsal; V,
ventral. Scale: 50 µm (C), 10 µm (B,E).
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Figure 2. Optogenetic stimulation of NPVF neurons activates 
serotonergic IRa neurons
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Figure 2. Optogenetic stimulation of NPVF neurons activates serotonergic IRa neurons.
(A-F) 6-dpf Tg(npvf:ReaChR-mCitrine); Tg(tph2:GCaMP6s-tdTomato) and Tg(npvf:eGFP);
Tg(tph2:GCaMP6s-tdTomato) animals are analyzed for GCaMP6s fluorescence levels in IRa
neurons before and after optogenetic stimulation of NPVF neurons. (A) Example of a 6-dpf
Tg(npvf:ReaChR-mCitrine); Tg(tph2:GCaMP6s-tdTomato) animal showing GCaMP6s and
tdTomato fluorescence in IRa neurons. White box indicates the region of the IRa analyzed in
subsequent panels. Green and magenta signals in the eyes are due to autofluorescence. (B)
Baseline GCaMP6s fluorescence in the IRa was first recorded using two-photon 920 nm light at 8
mW laser power for 38 s (30 frames). NPVF neurons were then optogentically stimulated using
920 nm light at 38 mW at 2.7 Hz for 3.7 s. GCaMP6s fluorescence in the IRa was then
immediately imaged again using 8 mW laser power for 44 s (35 frames). (C) Average GCaMP6s
fluorescence in IRa neurons for 10 frames before (Pre) and after (Post) optogenetic stimulation of
NPVF neurons. (D,E) Mean ± SEM GCaMP6s fluorescence of IRa neurons plotted as a function
of time, showing pre-stimulation and post-stimulation evoked responses for Tg(tph2:GCaMP6s-
tdTomato) animals that also contain a Tg(npvf:eGFP) (D,F) or Tg(npvf:ReaChR-mCitrine) (E,F)
transgene. Dashed grey line indicates 0% 𝝙F/F. n=number of neurons quantified from 4 animals
of each genotype. (F) Box plots quantify GCaMP6s 𝝙F/F values one frame after stimulation.
***p<0.0005, Mann-Whitney test. Scale: 100 µm (A), 10 µm (C).
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Figure 2 - figure supplement 1. Validation of two-photon-induced 
optogenetic stimulation of NPVF neurons. 
Figure 2 – figure supplement 1. Validation of two-photon-induced optogenetic stimulation of NPVF
neurons. Related to Figure 2. 6-dpf Tg(npvf:ReaChR); Tg(npvf:GCaMP6s-tdTomato) animals are analyzed for
GCaMP6s fluorescence levels in NPVF neurons before and after optogenetic stimulation of NPVF neurons. (A)
Example of a 6-dpf Tg(npvf:ReaChR); Tg(npvf:GCaMP6s-tdTomato) animal showing GCaMP6s and tdTomato
fluorescence in NPVF neurons. Green and magenta signals in the eyes are due to autofluorescence. White box
indicates the region of the hypothalamus that was stimulated and analyzed in subsequent panels. (B) Baseline
GCaMP6s fluorescence in NPVF neurons was first recorded using two-photon 920 nm light at 8 mW laser power
for 38 s (30 frames). NPVF neurons were then optogentically stimulated using 920 nm light at 38 mW at 2.7 Hz
for 3.7 s. GCaMP6s fluorescence in the IRa was then immediately imaged again using 8 mW laser power for 38
s (30 frames). (C) GCaMP6s fluorescence in NPVF neurons recorded one frame before (Pre) and after (Post)
optogenetic stimulation of NPVF neurons. (D,E) Structural images showing the location of each NPVF neuron
that were obtained by averaging 10 frames in the green (D) or red (E) channel. (F) Regions of interest (ROI) to
quantify GCaMP6s fluorescence in individual NPVF neurons were defined based on nuclear tdTomato
fluorescence. (G,H) GCaMP6s and mCitrine 𝝙F/F values for individual NPVF neurons (G, 9 neurons, 1 animal)
and mean ± SEM GCaMP6s and mCitrine 𝝙F/F values (H, 86 neurons, 5 animals) are plotted as function of time,
showing pre-stimulation and post-stimulation evoked responses. (I) Box plots quantify GCaMP6s and mCitrine𝝙F/F values one frame after stimulation for Tg(npvf:GCaMP6s-tdTomato) animals that also contain a
Tg(npvf:ReaChR) (blue) or Tg(npvf:eGFP) (black) transgene. n=number of neurons. ***p<0.0005, Mann-Whitney
test. Scale: 100 µm (A), 10 µm (C-F).
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Figure 3. Loss of npvf does not enhance the tph2 mutant sleep phenotype
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Figure 3. Loss of npvf does not enhance the tph2 mutant sleep
phenotype. (A-D) Average sleep for npvf +/-; tph2 +/- (black), npvf -/-; tph2 +/-
(dark blue), npvf +/-; tph2 -/- (gray), and npvf -/-; tph2 -/- (light blue) siblings.
The graph on the left shows data for all four genotypes. The three other graphs
show the same data as separate pair-wise comparisons. (E) Box plots quantify
sleep during the day (left) and night (right). White boxes indicate day. Black
boxes and gray shading indicate night. n=number of animals. ns p>0.05,
*p<0.05, **p<0.01, ***p<0.005, Two-way ANOVA with Holm-Sidak’s multiple
comparisons test for each indicated pair-wise comparison. The comparison in
red indicates no significant difference between npvf +/-; tph2 -/- and npvf -/-;
tph2 -/- siblings.
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Figure 4. Chemogenetic ablation of the RN abolishes NPVF neuron-induced sleep
Figure 4. Chemogenetic ablation of the RN abolishes NPVF neuron-induced sleep. (A) Schematic of
experiment. Treatment of animals with the small molecule MTZ results in ablation of serotonergic RN neurons in
Tg(tph2:eNTR-mYFP) animals but not in their non-transgenic siblings. Behavior is then monitored before and
during blue light exposure that stimulates npvf-expressing neurons in Tg(npvf:ReaChR) animals but not in their
non-transgenic siblings. (B) 5-dpf Tg(tph2:eNTR-mYFP) zebrafish brain showing serotonergic RN neurons and
some of their projections (green) and labeled with a 5-HT specific antibody (magenta). The bracketed region is
magnified in (C,D) to show co-labeling of RN neurons with mYFP and 5-HT immunoreactivity. Treatment of
Tg(tph2:eNTR-mYFP) animals with MTZ results in the loss of both 5-HT immunoreactivity (E) and YFP (F) in the
RN, but treatment with DMSO vehicle control does not (C,D). MTZ treatment in Tg(tph2:eNTR-mYFP) negative
siblings does not result in loss of RN neurons. Images are single 4 µm (B) and 0.6 µm (C-H) thick optical sections.
Scale: 50 µm (B), 10 µm (C-H). (I,J) Normalized locomotor activity (top) and sleep (bottom) of 5-dpf
Tg(npvf:ReaChR) (dark blue and light blue) and non-transgenic sibling controls (black and gray) zebrafish before
(Baseline) and during blue light exposure (Stimulation) in Tg(tph2:eNTR) negative animals (I) and in Tg(tph2:eNTR)
positive siblings (J). Box plots quantify locomotor activity and sleep during optogenetic stimulation normalized to
baseline of the same genotype. n=number of animals. ns p>0.05, *p<0.05, ***p<0.005, Mann-Whitney test.
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Figure 4 – figure supplement 1. Sleep induced by optogenetic stimulation of npvf-
expressing neurons is abolished in npvf and tph2 mutant animals. 
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Figure 4 – figure supplement 1. Sleep induced by optogenetic stimulation of npvf-expressing neurons is
abolished in npvf and tph2 mutant animals. Related to Figure 4. (A,B) 5-dpf Tg(npvf:ReaChR-mCitrine)
animals and their non-transgenic siblings were analyzed for changes in locomotor activity and sleep in a 96-well
plate optogenetic assay. NPVF neurons in the hypothalamus are labeled with the npvf:ReaChR-mCitrine transgene.
Green fluorescence in the eyes is due to autofluorescence. (C,D) Normalized locomotor activity (top) and sleep
(bottom) of Tg(npvf:ReaChR) (dark blue and light blue) and non-transgenic sibling control (black and gray) animals
before (Baseline) and during exposure to blue light (Stimulation) in npvf +/- (C) and npvf -/- (D) animals. (E,F) Same
as (C,D) but with tph2 mutant rather than npvf mutant. Because the animals see the blue light, they exhibit a brief
startle at light onset that is excluded from analysis, followed by a gradual increase in activity that plateaus after ~15
minutes. Box plots quantify locomotor activity and sleep for each animal during optogenetic stimulation normalized
to the baseline of all animals the same genotype. Stimulation of npvf-expressing neurons decreases locomotor
activity and increases sleep compared to non-transgenic sibling controls in npvf +/- animals (C) but not in npvf -/-
siblings (D), and in tph2 +/- animals (E) but not in tph2 -/- siblings (F). n=number of animals. ns p>0.05, *p<0.05,
***p<0.005, Mann-Whitney test.
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Figure 4 - figure supplement 2. Sleep induced by chemogenetic stimulation of 
npvf-expressing neurons is abolished in tph2 mutant animals. 
Figure 4 – figure supplement 2. Sleep induced by chemogenetic stimulation of npvf-expressing
neurons is abolished in tph2 mutant animals. Related to Figure 4. (A) Average sleep for 5-
dpf Tg(npvf:KalTA4); tph2+/- (black), Tg(npvf:KalTA4);tph2-/- (gray), Tg(npvf:KalTA4);Tg(UAS:TRPV1-
TagRFP-T);tph2+/- (dark blue), and Tg(npvf:KalTA4);Tg(UAS:TRPV1-TagRFP-T);tph2-/- (light blue) siblings
treated with 2 μM capsaicin. Box plots quantify sleep during the day (E) and night (F). White boxes indicate
day. Black boxes and gray shading indicate night. n=number of animals. ns p>0.05, *p<0.05,***p<0.005,
Two-way ANOVA with Holm-Sidak test.
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